AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (July 13, 2007). doi:10.1152/ajpheart.01320.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/H2262    most recent
01320.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutkowska, J.
Right arrow Articles by Jankowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutkowska, J.
Right arrow Articles by Jankowski, M.
Submitted on December 4, 2006
Accepted on July 2, 2007

Functional arginine-vasopressin system in early heart maturation

Jolanta Gutkowska1*, Malgorzata Miszkurka1, Bogdan Danalache1, Natig Gassanov2, Dongaho Wang1, and Marek Jankowski1

1 Laboratoire de biochimie cardiovasculaire, Centre hospitalier de l'Universite de Montreal (CHUM Hotel-Dieu), Montreal, Canada
2 Department of Internal Medicine III, University of Cologne, Cologne, Germany; Laboratoire de biochimie cardiovasculaire, Centre hospitalier de l'Universite de Montreal, Montreal, Canada

* To whom correspondence should be addressed. E-mail: jolanta.gutkowska{at}umontreal.ca.

Since the neurohypophyseal hormone 8-arginine-vasopressin (AVP) is involved in cardiovascular tissue hypertrophy and myocyte differentiation, it is possible that local AVP plays a role in heart maturation. AVP-specific radioimmunoassay, reverse transcription-polymerase chain reaction and immunoblotting measuring AVP receptors (VR) were used to investigate heart tissues from newborn and adult rats. To test AVP's role in differentiation and specialization into ventricle-like cardiomyocytes, we studied GFP-P19Cl6 stem cells holding green fluorescence protein (GFP) driven by the myosin light chain-2v (MLC-2v) promoter. VR1 transcripts and proteins were higher in adult than in newborn rat hearts. In contrast, VR2 increased from postnatal days 1 to 5, and was barely detected in the adult rat heart. In cardiomyocytes expressing troponin C, immunofluorescence revealed VR2 and VR1. Intracellular cAMP increased 6.5-fold and 8.9-fold in response to the selective VR2 agonist 1-desamino-8-D-AVP (DDAVP), after 1- and 24-h treatments, respectively. Cardiac AVP was high in 1-day-old rats (330 ± 26 pg/mg protein) and in 5-day-old rats (276 ± 53 pg/mg protein) but low (98 ± 15 pg/mg protein) in 66-day-old rats. AVP immunostaining was detected in the tunica adventitia and endothelium of the coronary vessels. The possible role of AVP in cardiomyogenesis was indicated by DDAVP-AVP-dependent differentiation of GFP-P19Cl6 stem cells into contracting cells displaying GATA4, a cardiac-specific marker, and ventricle-specific MLC. Together, it is suggested that the AVP system is implicated in postnatal cardiac maturation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.